These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5380827)

  • 21. Effect of cervical cancer screening in Scandinavia.
    Day NE
    Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Walton report and its subsequent impact on cervical cancer screening programs in Canada.
    Worth AJ
    Obstet Gynecol; 1984 Feb; 63(2):135-9. PubMed ID: 6694805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural history of Pap test screening in a rural population.
    Rosenfeld JA
    Tenn Med; 1998 May; 91(5):179-82. PubMed ID: 9584605
    [No Abstract]   [Full Text] [Related]  

  • 24. [Differences in cervical cancer mass screening results in Greater-Helsinki area].
    Nieminen P; Tarkkanen J; Timonen T; Meyer B; Hakama M; Anttila A
    Duodecim; 2000; 116(22):2489-96. PubMed ID: 12053343
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the efficiency of diagnosis of early cervical carcinoma by general practitioners and cytology screening programs in the Netherlands.
    Kirk RS; Boon ME
    Acta Cytol; 1981; 25(3):259-62. PubMed ID: 6942616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pilot studies on health control in Eskilstuna. 1. Principles of selection and non-attendance].
    Taube A
    Nord Med; 1966 Mar; 75(9):231-4. PubMed ID: 5910819
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gynecologic health screening in Canada and Sweden].
    Rubinstein E
    Lakartidningen; 1979 Mar; 76(12):1083-4. PubMed ID: 431202
    [No Abstract]   [Full Text] [Related]  

  • 28. Cervical cancer in Kentucky.
    Friedell GH; Ross FE; Tucker TC; Cook CC; Doering DL; Hilgers R; Milburn CS; Pursell SH; Spires SE; Hinton M; Sorrell C; Edwards MJ
    J Ky Med Assoc; 2000 Sep; 98(9):398-405. PubMed ID: 11022405
    [No Abstract]   [Full Text] [Related]  

  • 29. [Early screening for cervical carcinoma within primary prevention].
    Derese A; Geldhof A; Vuylsteek K
    Arch Belg; 1982; 40(9-10):381-416. PubMed ID: 7185335
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early diagnosis of cervix carcinoma II: model for mass screening of the female population based on the use of computers].
    Hofmann H; Neumann HG; Seidenschnur G
    Arch Geschwulstforsch; 1972; 40(4):362-76. PubMed ID: 4650822
    [No Abstract]   [Full Text] [Related]  

  • 31. [Registration of carcinoma in situ and squamous cell carcinoma of the uterine cervix in the screening area of Nijmegen from 1 January 1970 through 31 July 1982].
    Klinkhamer PJ; van der Graaf Y; Vooijs GP
    Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1979-83. PubMed ID: 6504185
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
    Juneja A; Murthy NS; Tuteja RK; Sardana S; Das DK
    Neoplasma; 1997; 44(4):272-4. PubMed ID: 9473783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arkansas cervical cancer program.
    Steinkamp RC; Roman-Lopez J; Kenney JA; Hairston MG; Hylton S; Hammett WN; Marsh S; Becton P; Collier S
    J Ark Med Soc; 1980 Jan; 76(1):312-22. PubMed ID: 6444400
    [No Abstract]   [Full Text] [Related]  

  • 34. [Epidemiology of cervical carcinoma and screening activities in GDR (author's transl)].
    Ebeling K; Tanneberger S; Nischan P; Johannsmeyer D; Herold HJ
    Zentralbl Gynakol; 1981; 103(17):985-96. PubMed ID: 7304026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast and cervical carcinoma: the correlation of activity limitations and rurality with screening, disease incidence, and mortality.
    Schootman M; Fuortes LJ
    Cancer; 1999 Sep; 86(6):1087-94. PubMed ID: 10491538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [2d interim report of mass screening for cervix carcinoma in the Nijmegen, Rotterdam and Utrecht test areas in 1976 and 1977].
    Janssens J
    Ned Tijdschr Geneeskd; 1980 Aug; 124(31):1306-7. PubMed ID: 7412905
    [No Abstract]   [Full Text] [Related]  

  • 38. Mass cervical cancer screening program by irrigation smear in Japan.
    Kawashima Y; Ino S; Tashiro K; Tachibana M; Masukawa T
    Obstet Gynecol; 1968 Jul; 32(1):17-23. PubMed ID: 5742086
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of cervical cancer in a women's prison.
    Audet-Lapointe P
    Can Med Assoc J; 1971 Mar; 104(6):509-11. PubMed ID: 5549991
    [No Abstract]   [Full Text] [Related]  

  • 40. Cervical and oral cancer screening in India.
    Sankaranarayanan R; Dinshaw K; Nene BM; Ramadas K; Esmy PO; Jayant K; Somanathan T; Shastri S
    J Med Screen; 2006; 13 Suppl 1():S35-8. PubMed ID: 17227640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.